1-2 of 2
Keywords: Cabazitaxel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer

Available to Purchase
Subject Area:
Further Areas
Yasuhide Miyoshi, Shinichi Sakamoto, Takashi Kawahara, Koichi Uemura, Yumiko Yokomizo, Hiroji Uemura
Journal: Urologia Internationalis
Urol Int (2019) 103 (3): 279–284.
https://doi.org/10.1159/000502655
Published Online: 28 August 2019
...Yasuhide Miyoshi; Shinichi Sakamoto; Takashi Kawahara; Koichi Uemura; Yumiko Yokomizo; Hiroji Uemura Background: Automated bone scan index (aBSI) change (ΔBSI) after treatment and survival in men with prostate cancer remains unclear. We evaluated the correlation between ΔBSI after cabazitaxel...
View article titled, Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer
Open the PDF for Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer in another window
Journal Articles

Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review

Available to Purchase
Subject Area:
Further Areas
Jost von Hardenberg, Maike Schwartz, Thorsten Werner, Stefan Fuxius, Arne Strauss, Thomas Stefan Worst, Philipp Nuhn, Christian Bolenz, Elmar Heinrich
Journal: Urologia Internationalis
Urol Int (2017) 99 (4): 414–421.
https://doi.org/10.1159/000477943
Published Online: 13 July 2017
... provide data during treatment with cabazitaxel (CAB), helping to improve the informed-consent process. Patients and Methods: We retrospectively reviewed patients treated with fourth-line or beyond CAB for mCRPC after failure of previous therapies with docetaxel, abiraterone acetate, enzalutamide...
View article titled, Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review
Open the PDF for Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review in another window